Skip to main content
logo
Ajooni Biotech Limited (NSE:AJOONI)
India flag India · Delayed Price · Currency is INR
3.080
+0.060 (1.99%)
Oct 6, 2026, 3:29 PM IST

Ajooni Biotech Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
2,1421,8241,147801.15744.88740.38
Revenue Growth
74.20%59.02%43.16%7.55%0.61%45.06%
Gross Profit
377.39344.5176.6497.6587.45100.24
Operating Income
54.0753.8227.8618.9419.7221.54
Net Income
39.7343.2233.7221.6111.2510.49
Earnings Per Share
0.230.250.200.250.190.21
EPS Growth
-27.69%-20.63%31.16%-9.39%180.50%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
3.745.4472.74.36.351.75
Total Debt
269.11177.6319.421.6851.7753.51
Net Cash (Debt)
-265.37-172.1953.31-17.37-45.42-51.75
Net Cash Growth
------
Net Cash Per Share
-1.54-1.000.31-0.20-0.76-1.02

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
--57.34-319.73229.1-55.7936.84
Capital Expenditures
--180.28-20.32-56.02-13.6-21.24
Free Cash Flow
--237.62-340.05173.09-69.3915.6
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
17.62%18.89%15.40%12.19%11.74%13.54%
Operating Margin
2.52%2.95%2.43%2.36%2.65%2.91%
Pretax Margin
2.50%3.15%3.77%3.74%2.12%1.97%
Profit Margin
1.85%2.37%2.94%2.70%1.51%1.42%
FCF Margin
--13.03%-29.65%21.61%-9.32%2.11%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
13.4115.3028.6023.9230.7764.20
P/FCF Ratio
---2.99-43.17
PS Ratio
0.250.360.840.650.470.91